Advertisement

Topics

LabCorp’s Acquisition of Chiltern Clears Antitrust Review

19:00 EDT 24 Aug 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
LabCorp® (NYSE: LH), a leading global life sciences company, announced today that the Federal Trade Commission had granted its request for early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvemen...

Other Sources for this Article

LabCorp
Media Contacts:
Pattie Kushner, 336-436-8263
Sue Maynard (Covance media), 336-436-8263
or
Investor Contact:
Scott Frommer, 336-436-5076

NEXT ARTICLE

More From BioPortfolio on "LabCorp’s Acquisition of Chiltern Clears Antitrust Review"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...